iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE)
The ETF aims to mirror the performance of the NASDAQ Biotechnology Index to generate total returns for investors through both capital appreciation and income.
ETF Info
| ISIN | IE00BYXG2H39 |
|---|---|
| WKN | A2DWAW |
| Issuer | iShares |
| Inception Date | Oct 19, 2017 |
| Category | Health & Biotech Equities |
| Index Tracked | Nasdaq Biotechnology |
| Domicile | Ireland |
| Distribution Policy | Accumulating |
| Asset Class | Equity |
Expense Ratio
2B70.DE has a high expense ratio of 0.35%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in iShares Nasdaq US Biotechnology UCITS ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
iShares Nasdaq US Biotechnology UCITS ETF had a return of -1.74% year-to-date (YTD) and 3.43% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -1.74% | 5.21% |
| 1 month | -4.94% | -4.30% |
| 6 months | 11.13% | 18.42% |
| 1 year | 3.43% | 21.82% |
| 5 years (annualized) | 5.69% | 11.27% |
| 10 years (annualized) | N/A | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.27% | 1.17% | -0.10% | |||||||||
| 2023 | -7.41% | 2.51% | 12.17% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 2B70.DE is 21, indicating that it is in the bottom 21% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
iShares Nasdaq US Biotechnology UCITS ETF(2B70.DE)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Nasdaq US Biotechnology UCITS ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Nasdaq US Biotechnology UCITS ETF was 30.87%, occurring on Jun 16, 2022. The portfolio has not yet recovered.
The current iShares Nasdaq US Biotechnology UCITS ETF drawdown is 14.56%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -30.87% | Aug 10, 2021 | 219 | Jun 16, 2022 | — | — | — |
| -23.14% | Oct 2, 2018 | 58 | Dec 21, 2018 | 231 | Nov 25, 2019 | 289 |
| -22.24% | Feb 20, 2020 | 17 | Mar 13, 2020 | 24 | Apr 20, 2020 | 41 |
| -15.65% | Feb 9, 2021 | 19 | Mar 5, 2021 | 105 | Aug 4, 2021 | 124 |
| -15.48% | Jul 21, 2020 | 36 | Sep 8, 2020 | 69 | Dec 14, 2020 | 105 |
Volatility
Volatility Chart
The current iShares Nasdaq US Biotechnology UCITS ETF volatility is 5.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.